Bank of Montreal’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$241K Buy
16,486
+832
+5% +$8.03K ﹤0.01% 2895
2026
Q1
$116K Sell
15,654
-2,442
-13% -$25.7K ﹤0.01% 3093
2025
Q4
$213K Buy
18,096
+24
+0.1% +$259 ﹤0.01% 2812
2025
Q3
$140K Sell
18,072
-10,996
-38% -$77K ﹤0.01% 2882
2025
Q2
$212K Buy
29,068
+880
+3% +$7.1K ﹤0.01% 2778
2025
Q1
$268K Buy
28,188
+3,565
+14% +$44.5K ﹤0.01% 2573
2024
Q4
$406K Buy
24,623
+2,569
+12% +$39.9K ﹤0.01% 2362
2024
Q3
$320K Sell
22,054
-72,537
-77% -$1.13M ﹤0.01% 2729
2024
Q2
$1.32M Sell
94,591
-4,150
-4% -$58.8K ﹤0.01% 1882
2024
Q1
$1.57M Sell
98,741
-11,123
-10% -$172K ﹤0.01% 1770
2023
Q4
$1.87M Buy
109,864
+2,876
+3% +$47.1K ﹤0.01% 1726
2023
Q3
$1.44M Buy
106,988
+72,919
+214% +$1.08M ﹤0.01% 1872
2023
Q2
$572K Buy
34,069
+2,144
+7% +$35.3K ﹤0.01% 2497
2023
Q1
$604K Buy
31,925
+5,585
+21% +$79.6K ﹤0.01% 2359
2022
Q4
$257K Sell
26,340
-3,238
-11% -$30.2K ﹤0.01% 3012
2022
Q3
$289 Buy
29,578
+13,107
+80% +$130K ﹤0.01% 2952
2022
Q2
$152 Sell
16,471
-24,733
-60% -$236K ﹤0.01% 3358
2022
Q1
$535K Buy
41,204
+2,397
+6% +$50.4K ﹤0.01% 2782
2021
Q4
$1.33M Sell
38,807
-19,238
-33% -$753K ﹤0.01% 1792
2021
Q3
$2.83M Buy
58,045
+163
+0.3% +$7.55K ﹤0.01% 1909
2021
Q2
$2.71M Sell
57,882
-34,362
-37% -$1.52M ﹤0.01% 1904
2021
Q1
$4.42M Sell
92,244
-18,206
-16% -$948K ﹤0.01% 1414
2020
Q4
$5.89M Sell
110,450
-2,403
-2% -$109K ﹤0.01% 1294
2020
Q3
$4.35M Sell
112,853
-10,367
-8% -$385K ﹤0.01% 1281
2020
Q2
$4.47M Buy
123,220
+10,490
+9% +$291K ﹤0.01% 1216
2020
Q1
$3.05M Sell
112,730
-28,040
-20% -$840K ﹤0.01% 1218
2019
Q4
$4.12M Buy
140,770
+71,740
+104% +$1.71M ﹤0.01% 1461
2019
Q3
$1.32M Buy
69,030
+49,856
+260% +$1.17M ﹤0.01% 1948
2019
Q2
$419K Buy
19,174
+6,399
+50% +$140K ﹤0.01% 2521
2019
Q1
$261K Buy
12,775
+6,398
+100% +$111K ﹤0.01% 2597
2018
Q4
$80K Buy
6,377
+5,939
+1,356% +$88.5K ﹤0.01% 3065
2018
Q3
$7K Buy
438
+40
+10% +$553 ﹤0.01% 4035
2018
Q2
$5K Sell
398
-802
-67% -$8.83K ﹤0.01% 4130
2018
Q1
$10K Buy
+1,200
New +$9.72K ﹤0.01% 3763
2017
Q3
Sell
-59,953
Closed -$537K 4269
2017
Q2
$537K Hold
59,953
﹤0.01% 2242
2017
Q1
$473K Hold
59,953
﹤0.01% 2121
2016
Q4
$536K Sell
59,953
-14,378
-19% -$123K ﹤0.01% 2107
2016
Q3
$611K Sell
74,331
-5,228
-7% -$43.9K ﹤0.01% 2013
2016
Q2
$640K Sell
79,559
-8,728
-10% -$70K ﹤0.01% 2013
2016
Q1
$595K Hold
88,287
﹤0.01% 1975
2015
Q4
$696K Buy
88,287
+913
+1% +$6.69K ﹤0.01% 1864
2015
Q3
$501K Sell
87,374
-3,461
-4% -$21.4K ﹤0.01% 1850
2015
Q2
$491K Buy
90,835
+10,200
+13% +$52.6K ﹤0.01% 1982
2015
Q1
$376K Sell
80,635
-10,296
-11% -$44.8K ﹤0.01% 2075
2014
Q4
$379K Buy
90,931
+702
+0.8% +$3.23K ﹤0.01% 2202
2014
Q3
$470K Sell
90,229
-9,758
-10% -$50.1K ﹤0.01% 2104
2014
Q2
$332K Buy
+99,987
New +$332K ﹤0.01% 2292
2013
Q3
Sell
-12,195
Closed -$49K 3882
2013
Q2
$49K Buy
+12,195
New +$46.5K ﹤0.01% 2732

Other funds holding NEO

Bank of Montreal's NEO Position: Q2 2026 in Review

Bank of Montreal increased its NeoGenomics (NEO) stake by 5.3% in Q2 2026, buying an estimated $8.03K and bringing the position to 16,486 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #2895.

Bank of Montreal first reported a position in NEO in Q2 2013 and has held it in 48 quarters since. The position peaked at $5.89M in Q4 2020. 254 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Bank of Montreal held 16,486 shares of NeoGenomics worth $241K as of Q2 2026.
  • Bank of Montreal bought 832 NeoGenomics shares in Q2 2026, an estimated $8.03K.
  • NeoGenomics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2895 holding.
  • Bank of Montreal first reported a position in NeoGenomics in Q2 2013 and has held it in 48 quarters since.
  • Bank of Montreal's NeoGenomics position peaked at $5.89M in Q4 2020.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.